|
ATP6V0A2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.557060E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.620200E-03 |
| Normal-vs-Stage2 |
1.127940E-02 |
| Normal-vs-Stage3 |
9.60499999980158E-07 |
| Normal-vs-Stage4 |
1.239830E-03 |
| Stage1-vs-Stage2 |
5.785400E-01 |
| Stage1-vs-Stage3 |
1.920600E-03 |
| Stage1-vs-Stage4 |
1.825840E-01 |
| Stage2-vs-Stage3 |
1.246200E-01 |
| Stage2-vs-Stage4 |
5.609400E-01 |
| Stage3-vs-Stage4 |
4.096200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.7295999999969E-05 |
| Normal-vs-AfricanAmerican |
3.584300E-02 |
| Normal-vs-Asian |
4.941000E-01 |
| Caucasian-vs-AfricanAmerican |
3.223400E-01 |
| Caucasian-vs-Asian |
4.487200E-01 |
| AfricanAmerican-vs-Asian |
7.245400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.444410E-04 |
| Normal-vs-Female |
1.142280E-03 |
| Male-vs-Female |
3.415200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.959080E-03 |
| Normal-vs-Age(41-60Yrs) |
4.642100E-03 |
| Normal-vs-Age(61-80Yrs) |
7.54729999999926E-05 |
| Normal-vs-Age(81-100Yrs) |
2.623700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.503430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.340000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.051800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.372960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.468000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.682400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.486200E-01 |
| Normal-vs-Grade 2 |
3.278800E-03 |
| Normal-vs-Grade 3 |
2.21300000002866E-06 |
| Normal-vs-Grade 4 |
1.196070E-03 |
| Grade 1-vs-Grade 2 |
2.113400E-01 |
| Grade 1-vs-Grade 3 |
3.505900E-02 |
| Grade 1-vs-Grade 4 |
1.225950E-01 |
| Grade 2-vs-Grade 3 |
2.537800E-02 |
| Grade 2-vs-Grade 4 |
2.229000E-01 |
| Grade 3-vs-Grade 4 |
8.906600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.158800E-04 |
| Normal-vs-ccB subtype |
8.956900E-03 |
| ccA subtype-vs-ccB subtype |
4.255000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.724100E-03 |
| Normal-vs-N1 |
1.856240E-01 |
| N0-vs-N1 |
6.814200E-01 |
|
|
